By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


GlycoMimetics, Inc. 

14915 Broschart Road, Suite 200

Rockville   Maryland  20850  U.S.A.
Phone: 301-738-1166 Fax:




Company News
GlycoMimetics, Inc. (GLYC) To Present At 18th Annual BIO CEO & Investor Conference 2/2/2016 11:06:01 AM
GlycoMimetics, Inc. (GLYC) Poster Shows GMI-1271 Reverses Drug Resistance In Multiple Myeloma Models 12/7/2015 2:00:26 PM
GlycoMimetics, Inc. (GLYC) Presents At American Society of Hematology Meeting First-In-Human Data Showing Favorable Safety, Metabolic And Biomarker Profiles For GMI-1271 12/7/2015 1:58:39 PM
GlycoMimetics, Inc. (GLYC) Highlights Preclinical Data In Oral Presentation At American Society of Hematology Meeting Demonstrating Impact Of GMI-1271 On T Memory Stem Cells 12/7/2015 10:33:41 AM
GlycoMimetics, Inc. (GLYC) Presents Preclinical Data At American Society of Hematology Annual Meeting Showing GMI-1359 Enhances Efficacy Of Chemotherapy In FLT-3 AML Model 12/7/2015 10:32:16 AM
GlycoMimetics, Inc. (GLYC) To Present At Two Investor Conferences In November 11/13/2015 10:49:08 AM
GlycoMimetics, Inc. (GLYC) Reports Third Quarter 2015 Results 11/12/2015 11:45:20 AM
GlycoMimetics, Inc. (GLYC) Announces Initiation Of First Clinical Trial Evaluating Subcutaneous Administration Of Rivipansel 10/29/2015 11:07:51 AM
GlycoMimetics, Inc. (GLYC) Announces Issuance Of U.S. Composition Of Matter Patent For Drug Candidate GMI-1271 9/1/2015 10:09:44 AM
GlycoMimetics, Inc. (GLYC) To Present At The Canaccord Genuity Growth Conference 8/10/2015 10:07:28 AM